Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time? A word of caution

Strahlenther Onkol. 2013 Dec;189(12):993-5. doi: 10.1007/s00066-013-0459-2. Epub 2013 Nov 2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / genetics*
  • CpG Islands / genetics
  • DNA Methylation / genetics*
  • DNA Modification Methylases / genetics*
  • DNA Repair Enzymes / genetics*
  • DNA, Neoplasm / genetics
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics
  • Glioblastoma / diagnosis*
  • Glioblastoma / genetics*
  • Humans
  • Prognosis
  • Tumor Suppressor Proteins / genetics*

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Genetic Markers
  • Tumor Suppressor Proteins
  • DNA Modification Methylases
  • MGMT protein, human
  • DNA Repair Enzymes